BioPharm International, May 2010 Issue (PDF)
Pfizer’s Qbd Approach to Achieving Process Understanding
Healthcare Reform Expands Coverage, Promotes Innovation
Broader benefits and biosimilars will offset hefty fees and discounts while preserving R&D incentives.
Pandemic Response: Progress and Challenges
We all know that experience is the best teacher. With H1N1, we have a great opportunity to learn important lessons.
Managing CMOs with Complementary Capabilities
Formulation strategy is an important consideration when selecting and managing outsourced biopharmaceutical development programs.
Are You Ready for a Post-Reform World?
The industry must be prepared for the impact of the sweeping changes expected from the new legislation.
Building Partnerships Between Academia and Biosciences Companies
This practicum combines business elements with scientific concepts.
Applying Computational Fluid Dynamics Technology in Bioprocesses-Part 2
Computational fluid dynamics can resolve performance problems.
Designing in Quality: Approaches to Defining the Design Space for a Monoclonal Antibody Process
How to use risk assessment strategies to integrate operations.
